BioHealth News

QIAGEN announces partnership with Penn State University to advance microbiome sciences

QIAGEN announces partnership with Penn State University to advance microbiome sciences

Read More
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs

MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs

Read More
Technical.ly: ETC, One of Baltimore’s Oldest Entrepreneurship Incubators, Names Arti Santhanam as New Executive Director

Technical.ly: ETC, One of Baltimore’s Oldest Entrepreneurship Incubators, Names Arti Santhanam as New Executive Director

Read More
Haystack Oncology and TriSalus Life Sciences Enter Research Collaboration

Haystack Oncology and TriSalus Life Sciences Enter Research Collaboration

Read More
UMB Researchers Aim to Enhance Vaccines with $9.4M NIH Grant

UMB Researchers Aim to Enhance Vaccines with $9.4M NIH Grant

Read More
STEMCELL Technologies Announces Acquisition of Gaithersburg’s Propagenix Inc.

STEMCELL Technologies Announces Acquisition of Gaithersburg’s Propagenix Inc.

Read More
Genetic Engineering & Biotechnology News: AI in Drug Discovery: Trust, but Verify

Genetic Engineering & Biotechnology News: AI in Drug Discovery: Trust, but Verify

Read More
Virginia Catalyst Announces Grant Round 15 Awarded Projects

Virginia Catalyst Announces Grant Round 15 Awarded Projects

Read More
BioHealth Innovation, Inc.’s Rich Bendis Named Finalist for the Community Builder Award in the 2023 BioHealth Capital Region Annual Awards

BioHealth Innovation, Inc.’s Rich Bendis Named Finalist for the Community Builder Award in the 2023 BioHealth Capital Region Annual Awards

Read More
Luminoah’s Receives $463,000 Grant from Virginia Catalyst

Luminoah’s Receives $463,000 Grant from Virginia Catalyst

Read More
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery

REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery

Read More
BioHealth Innovation, Inc. (BHI) Welcomes Peter Ronco as a New Member of the Board of Directors

BioHealth Innovation, Inc. (BHI) Welcomes Peter Ronco as a New Member of the Board of Directors

Read More
Children’s National Novel AI platform matches cardiologists in detecting rheumatic heart disease

Children’s National Novel AI platform matches cardiologists in detecting rheumatic heart disease

Read More
BioHealth Innovation Insights from the 2024 J.P. Morgan Healthcare Conference

BioHealth Innovation Insights from the 2024 J.P. Morgan Healthcare Conference

Read More
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

Read More
View All Posts